Chronic kidney disease (CKD) is associated with the development of mineral bone disorder
(MBD), osteoporosis, and fragility fractures. Among CKD patients, adynamic bone disease or …

Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD)
characterized by disruption of normal mineral homeostasis within the body. One or more of …

Patients with chronic kidney disease (CKD) are more likely to experience falls and fractures
due to renal osteodystrophy and the high prevalence of risk factors for falls. However, it is …

CKD mineral and bone disease is a common complication of kidney disease, and it affects
the majority of patients with moderate to severe CKD. Recently, prospective studies have …

Context The effects of long-term exposure to denosumab in individuals with renal
insufficiency are unknown. Objective This post hoc analysis evaluates the long-term safety …

Background: Complications of chronic kidney disease (CKD) include weak bones and
increased fracture risk. Purpose: To review the benefits and harms of osteoporosis …

Mineral and bone disorders including osteoporosis are common in dialysis patients and
contribute to increased morbimortality. However, whether denosumab and alendronate are …

Abstract Purpose of Review Osteoporosis is commonly diagnosed through the clinical
assessment of bone quantity using bone mineral density; however, the primary clinical …

Questions remain about whether the increased risk of fractures in patients with type 2
diabetes (T2DM) is related mainly to increased risk of falling or to bone‐specific properties …

Methods In a single-arm, open-label, 36-week prospective trial, we hypothesized that
etelcalcetide improves bone quality and strength without damaging bone–tissue quality …